Crossmark

The roles of the inhibitory autophagy regulator Rubicon in the heart: A new therapeutic target to prevent cardiac cell death

Crossref DOI link: https://doi.org/10.1038/s12276-021-00600-3

Published Online: 2021-04-14

Published Print: 2021-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nah, Jihoon https://orcid.org/0000-0003-2254-2233
Zablocki, Daniela

Sadoshima, Junichi
Funding

Funding for this research was provided by:

American Heart Association (18POST34050036)

U.S. Department of Health & Human Services | U.S. Public Health Service (HL67724)

U.S. Department of Health & Human Services | U.S. Public Health Service (HL91469)

U.S. Department of Health & Human Services | U.S. Public Health Service (HL112330)

U.S. Department of Health & Human Services | U.S. Public Health Service (HL138720)

U.S. Department of Health & Human Services | U.S. Public Health Service (HL144626)

U.S. Department of Health & Human Services | U.S. Public Health Service (HL150881)

U.S. Department of Health & Human Services | U.S. Public Health Service (AG23039)

U.S. Department of Health & Human Services | U.S. Public Health Service

U.S. Department of Health & Human Services | U.S. Public Health Service

U.S. Department of Health & Human Services | U.S. Public Health Service

U.S. Department of Health & Human Services | U.S. Public Health Service

U.S. Department of Health & Human Services | U.S. Public Health Service

U.S. Department of Health & Human Services | U.S. Public Health Service

Fondation Leducq (15CBD04)
License Information

Text and Data Mining valid from 2021-04-01

Version of Record valid from 2021-04-14
More Information

Article History

Received: 21 December 2020

Revised: 3 March 2021

Accepted: 8 March 2021

First Online: 14 April 2021

Conflict of interest

: The authors declare no competing interest.

Document is current

Any future updates will be listed below